Terns Pharmaceuticals, Inc. (TERN)

47.09 +2.48 (+5.56%) USD  |  NASDAQ  |  Dec 11, 16:00
48.45 +1.36 (+2.89%) After-Hours: 07:04
More

Terns Pharmaceuticals Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for TERN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Pfizer Inc. Upgrade
Altimmune, Inc. Upgrade
Viking Therapeutics, Inc. --
Rhythm Pharmaceuticals, Inc. Upgrade